Stryker Corp (SYK.N)
71.22USD
1 Aug 2013
$0.76 (+1.08%)
$70.46
$70.65
$71.43
$70.01
246,853
406,993
$71.43
$50.96
About
Overall
| Beta: | 0.97 |
| Market Cap (Mil.): | $26,643.19 |
| Shares Outstanding (Mil.): | 378.13 |
| Dividend: | 0.26 |
| Yield (%): | 1.50 |
Financials
| SYK.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 23.63 | 27.50 | 37.76 |
| EPS (TTM): | 2.98 | -- | -- |
| ROI: | 9.83 | 9.26 | 18.76 |
| ROE: | 13.77 | 12.54 | 19.59 |
Stryker quarterly profit falls short of Wall Street estimates
- U.S. orthopedic implant maker Stryker Corp on Thursday reported net profit fell 35 percent in the second quarter, but said adjusted earnings rose about 1 percent as sales of its hip, knee and spine products improved.
UPDATE 1-Stryker quarterly profit falls short of Wall Street estimates
July 18 - U.S. orthopedic implant maker Stryker Corp on Thursday reported net profit fell 35 percent in the second quarter, but said adjusted earnings rose about 1 percent as sales of its hip, knee and spine products improved.
UPDATE 1-Stryker names Dentsply executive as chief financial officer
April 8 - Medical products maker Stryker Corp on Monday named William Jellison as chief financial officer, replacing Dean Bergy, who was interim CFO.
Stryker names new chief financial officer
April 8 - Medical products maker Stryker Corp on Monday said it named William Jellison chief financial officer, replacing Dean Bergy, who was serving as interim CFO.
FDA warns Stryker on quality issues, marketing practices
- Orthopedic implant maker Stryker Corp said it received a warning letter from the U.S. Food and Drug Administration related to quality concerns at its Portage, Michigan facility.
UPDATE 1-FDA warns Stryker on quality issues, marketing practices
March 12 - Orthopedic implant maker Stryker Corp said it received a warning letter from the U.S. Food and Drug Administration related to quality concerns at its Portage, Michigan facility.
Competitors
| Price | Change | |
|---|---|---|
| Olympus Corp (7733.T) | ¥3,075 | +35.00 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Medtronic, Inc. (MDT.N) | $55.49 | +0.25 |
| Covidien plc (COV.N) | $62.93 | +1.30 |
| Zimmer Holdings, Inc. (ZMH.N) | $84.47 | +0.99 |
| Smith & Nephew plc (SN.L) | 787.50p | +3.00 |
| Biomet Inc (BMET.OQ) | -- | -- |
| Hill-Rom Holdings, Inc. (HRC.N) | $37.62 | +0.55 |
| CONMED Corporation (CNMD.OQ) | $33.03 | +0.23 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (SYK). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

